authors
- Fu, SYF
- Murtha, A
- Herberts, C
- Yip, S
- Angeles, A
- Hotte, Sebastien
- Alshangiti, A
- Tran, B
- Taavitsainen, S
- Annala, M
- Saad, F
- Iqbal, NN
- Wyatt, AW
- Chi, KN
Activating mutations in AKT1/PIK3CA are associated with poor clinical outcomes in metastatic prostate cancer (mPC)
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2019
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Annals of Oncology Journal